Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  MEDNAX Inc    MD

MEDNAX INC (MD)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales2 439-3 1833 4313 6603 915
EBITDA559654695579613646
Operating profit (EBIT)513632666479511537
Pre-Tax Profit (EBT)------
Net income317-325247264280
P/E ratio20,820,019,119,217,816,7
EPS ( $ )3,183,583,492,662,873,05
Dividend per Share ( $ )------
Yield------
Reference price ( $ )66.1171.6666.6651.0751.0751.07
Announcement Date01/29/2015
11:00am
-02/07/2017
11:00am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt515-1 6392 5852 5042 933
Finance------
Operating income (EBITDA)559654695579613646
Leverage
(Debt/EBITDA)
0,92x-2,36x4,47x4,08x4,54x
Capital Expenditure18,127,139,345,739,045,3
Book Value Per Share (BVPS)22,6 $25,9 $29,5 $31,9 $34,1 $34,3 $
Cash Flow per Share4,23 $3,92 $4,77 $4,61 $4,11 $4,10 $
Announcement Date01/29/2015
11:00am
02/07/2017
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 4 783 M$ -
Entreprise Value (EV) 7 368 M$ 7 287 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 19,2x 17,8x
Capitalization / Revenue 1,39x 1,31x
EV / Revenue 2,15x 1,99x
EV / EBITDA 12,7x 11,9x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 1,60x 1,50x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 14,0% 14,0%
operating Leverage (Delta EBIT / Delta Sales) - 0,99x
Net Margin (Net Profit / Revenue) 7,20% 7,21%
ROA (Net Profit / Asset) 5,50% 5,10%
ROE (Net Profit / Equities) 10,4% 10,1%
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,33% 1,07%
Cash Flow / Sales 12,6% 10,5%
Capital Intensity (Assets / Sales) 1,31x 1,41x
Financial Leverage (Net Debt / EBITDA) 4,47x 4,08x
EPS & Dividend